Position in EVFM
as of Sep 30, 2022
· filed Nov 3, 2022
Position Value
$0
-$7,269 QoQ
Shares Held
3
-94.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EVFM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,710,275,160 across 455 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in EVFM
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2022-09-30 | — | 433 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $7,269 | 6,433 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $12,408 | 36,500 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $13,722 | 36,500 | Shares | Defined | 2022-02-23 | |
| 2021-09-30 | $34,626 | 46,858 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $51,168 | 45,283 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $164,865 | 94,210 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $132,196 | 54,854 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $203,749 | 86,335 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $217,707 | 76,929 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $24,956 | 4,691 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||